Name: Acute Care
Brand: ECRI
SKU: NIL
Availability: InStock
Rating: 4.6 (5 reviews)

ISMP Newsroom

ISMP

Media Inquiries

For media inquiries and interviews with ISMP's subject matter experts, please contact Renee Brehio at rbrehio@ismp.org.

Tous les articles

Press Coverage

Press Coverage

Ochsner Children’s Hospital and ISMP Launch First-of-its-Kind Pharmacy Fellowship

This article appeared on the Biz New Orleans website on March 27, 2025.

Press Coverage

Press Coverage

APhA 2025: Strategies for Reducing Errors in Community Pharmacy Settings

This article appeared on the Pharmacy Times website on March 21, 2025.

Press Coverage

Press Coverage

ISMP: Human Factors a Key to Medication Safety

This article appeared on the Pharmacy Practice News website on March 18, 2025.

Press Coverage

Press Coverage

Best Practices for Ambulatory Pharmacies: ISMP

This article appeared on the Becker’s Hospital Review website on March 6, 2025.

Press Coverage

Press Coverage

Let’s Correct Misinformation about Compounded Drugs

This article appeared on the Association of Health Care Journalists website on February 24, 2025.

Press Coverage

Press Coverage

Compounded GLP-1s Require Extra Vigilance

This article appeared on the Specialty Pharmacy Continuum website on December 18, 2024.

Stay Connected

Get medication safety news, event invitations and updates straight to your inbox!

Social Media

View the Latest from ECRI

News

HANYS Marketplace partners with ECRI to improve patient safety and reduce preventable harm in healthcare

HANYS Marketplace® has partnered with ECRI, a nonprofit organization advancing the safety and quality of healthcare, to provide New York’s hospitals and health systems with evidence-based solutions...

News

ECRI Names Cottage Health Winner of 2026 Health Technology Excellence Award

Innovative blood management initiative recognized for reducing waste through proactive interfacility transfers. ECRI, a nonprofit organization advancing the safety and quality of healthcare, has ho...

News

ECRI & ISMP Statement in Response to PCAC Decision on Compounding Peptides

The FDA Pharmacy Compounding Advisory Committee (PCAC) decided to recommend adding most of the peptides under consideration during its July 23-24, 2026, meeting to the 503A Bulks List, despite subs...

View all